RETRACTED ARTICLE:LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
Ahsan Habib(University of South Florida), Jun Tan(Guiyang Medical University)
Cited by 22
Related Papers
CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice
|Journal of Neuroscience|2011|89
Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease
|Translational Psychiatry|2023|27
CD45RB Is a Novel Molecular Therapeutic Target to Inhibit Aβ Peptide-Induced Microglial MAPK Activation
|PLoS ONE|2008|21
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice
|EMBO Molecular Medicine|2024|12
Therapeutic modulation of Alzheimer’s disease with biological (HUCBS) and pharmacological (LISPRO) approaches
|Digital Commons - University of South Florida (University of South Florida)|2018|0